CHA News

FDA Authorizes Booster Doses for Moderna, Johnson & Johnson COVID-19 Vaccines 

For CEOs, CMOs, CNOs, COOs, and infection prevention, quality & patient safety, employee safety staff

The Food and Drug Administration (FDA) has amended emergency use authorization (EUA) for COVID-19 vaccines to allow booster doses for the Moderna and Johnson & Johnson vaccines. Specifically, the EUA allows for a single-dose booster in the following circumstances:  The use of a single booster dose of the Moderna COVID-19 vaccine may be administered at least six months after completion of the primary series to...

This content is restricted to members.